Jay Friedman

3.5k citations
56 papers · 2.7k · h-index 27

Impact in

  • Immunology top 2%
    • Immune cells in cancer
    • Immunotherapy and Immune Responses
    • Immune Cell Function and Interaction
  • Oncology top 2%
    • Cancer Immunotherapy and Biomarkers
    • CAR-T cell therapy research
    • Cancer-related Molecular Pathways

Papers in

  • Oncology 23
    • Cancer Immunotherapy and Biomarkers 9
    • Cancer-related Molecular Pathways 5
    • CAR-T cell therapy research 4
  • Immunology 21
    • Immune cells in cancer 8
    • Immunotherapy and Immune Responses 6
    • interferon and immune responses 3
    • Immune Cell Function and Interaction 3
Co-authors
Carter Van Waes (20 shared papers)Clint Allen (29 shared papers)Paúl E. Clavijo (17 shared papers)Zhong Chen (10 shared papers)Ellen Moore (10 shared papers)Yvette Robbins (14 shared papers)Jeffrey Schlom (9 shared papers)Husam Ghanim (3 shared papers)
Journals
Clinical Cancer Research (6 papers)Oral Oncology (4 papers)Cancer Research (4 papers)OncoImmunology (4 papers)Journal for ImmunoTherapy of Cancer (3 papers)
Partner nations
United StatesGermanyMalaysia

In The Last Decade

Jay Friedman

54 papers receiving 2.7k citations

Peers

Jay Friedman
Comparison fields: 5 of 114
  • Immunology 998
  • Oncology 1.1k
  • Otorhinolaryngology 107
  • Cancer Research 317
  • Molecular Biology 749
Replace Fabrice Journé with:
Fabrice Journé Belgium
Kwan‐Hwa Chi Taiwan
Mélanie Bruchard France
Caio A. Leite Brazil
Shih Sheng Jiang Taiwan
Eric Kenneth Parkinson United Kingdom
Yanhong Ni China
Ko‐Jiunn Liu Taiwan
Wan Du China
Laura S. Angelo United States
Jay Friedman relative to Fabrice Journé Belgium Fabrice Journé's profile →
Citations per field
00.5×1.5×1.8×
Fabrice Journé · 1×
Citations per year

Countries citing papers authored by Jay Friedman

Since Specialization
Citations

This map shows the geographic impact of Jay Friedman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jay Friedman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jay Friedman more than expected).

Fields of papers citing papers by Jay Friedman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jay Friedman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jay Friedman. The network helps show where Jay Friedman may publish in the future.

Co-authors

The 25 scholars most cited alongside Jay Friedman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Jay Friedman Line = papers co-authored together Jay Friedman links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 56 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Inhibition of MDSC Trafficking with SX-682, a CXCR1/2 Inhibitor, Enhances NK-Cell Immunotherapy in Head and Neck Cancer Models
Clinical Cancer Research ·Sarah Greene, Yvette Robbins, Wojciech K. Mydlarz, Angel P. Huynh, Nicole C. Schmitt, Jay Friedman, Lucas A. Horn, Claudia Palena, Jeffrey Schlom, Dean Y. Maeda, John A. Zebala, Paúl E. Clavijo, Clint Allen
2019235
2
Differential Effects of Cream, Glucose, and Orange Juice on Inflammation, Endotoxin, and the Expression of Toll-Like Receptor-4 and Suppressor of Cytokine Signaling-3
Diabetes Care ·Rupali Deopurkar, Husam Ghanim, Jay Friedman, Sanaa Abuaysheh, Chang Ling Sia, Priya Mohanty, Prabhakar Viswanathan, Ajay Chaudhuri, Paresh Dandona
2010210
3
Inhibiting myeloid-derived suppressor cell trafficking enhances T cell immunotherapy
JCI Insight ·Lillian Sun, Paúl E. Clavijo, Yvette Robbins, Priya Patel, Jay Friedman, Sarah Greene, Rita Das, Chris Silvin, Carter Van Waes, Lucas A. Horn, Jeffrey Schlom, Claudia Palena, Dean Y. Maeda, John A. Zebala, Clint Allen
2019199
4
Anti-PD-L1 Efficacy Can Be Enhanced by Inhibition of Myeloid-Derived Suppressor Cells with a Selective Inhibitor of PI3Kδ/γ
Cancer Research ·Ruth J. Davis, Ellen Moore, Paúl E. Clavijo, Jay Friedman, Harrison Cash, Zhong Chen, Chris Silvin, Carter Van Waes, Clint Allen
2017189
5
EGFR–PI3K–AKT–mTOR signaling in head and neck squamous cell carcinomas: attractive targets for molecular-oriented therapy
Expert Opinion on Therapeutic Targets ·Christian Freudlsperger, (unknown), Jay Friedman, Vishnu R. Kannabiran, Zhong Chen, Carter Van Waes
2010152
6
Glucose ingestion induces an increase in intranuclear nuclear factor κB, a fall in cellular inhibitor κB, and an increase in tumor necrosis factor α messenger RNA by mononuclear cells in healthy human subjects
Metabolism ·Ahmad Aljada, Jay Friedman, Husam Ghanim, Priya Mohanty, Deborah Hofmeyer, Ajay Chaudhuri, Paresh Dandona
2006136
7
Host Immunity Following Near-Infrared Photoimmunotherapy Is Enhanced with PD-1 Checkpoint Blockade to Eradicate Established Antigenic Tumors
Cancer Immunology Research ·Tadanobu Nagaya, Jay Friedman, Yasuhiro Maruoka, Fusa Ogata, Shuhei Okuyama, Paúl E. Clavijo, Peter L. Choyke, Clint Allen, Hisataka Kobayashi
2019124
8
PD-1 blockade reverses adaptive immune resistance induced by high-dose hypofractionated but not low-dose daily fractionated radiation
OncoImmunology ·Megan V. Morisada, Paúl E. Clavijo, Ellen Moore, Lillian Sun, Michael M. Chamberlin, Carter Van Waes, James W. Hodge, James B. Mitchell, Jay Friedman, Clint Allen
2017115
9
ΔNp63 Versatilely Regulates a Broad NF-κB Gene Program and Promotes Squamous Epithelial Proliferation, Migration, and Inflammation
Cancer Research ·Xinping Yang, Hai Lü, Bin Yan, Rose-Anne Romano, Yansong Bian, Jay Friedman, Praveen Duggal, Clint Allen, Ryan Chuang, Reza Ehsanian, Han Si, Satrajit Sinha, Carter Van Waes, Zhong Chen
2011104
10
A signal network involving coactivated NF‐κB and STAT3 and altered p53 modulates BAX/BCL‐XL expression and promotes cell survival of head and neck squamous cell carcinomas
International Journal of Cancer ·TL Lee, Jason Yeh, Jay Friedman, Bin Yan, Xinping Yang, Ning T. Yeh, Carter Van Waes, Zhong Chen
200897
11
Current and potential inflammation targeted therapies in head and neck cancer
Current Opinion in Pharmacology ·Frederick Wang, Pattatheyil Arun, Jay Friedman, Zhong Chen, Carter Van Waes
200983
12
Synthesis and Evaluation of Paclitaxel-Loaded Gold Nanoparticles for Tumor-Targeted Drug Delivery
Bioconjugate Chemistry ·Giulio F. Paciotti, Jielu Zhao, Shugeng Cao, Peggy J. Brodie, Lawrence Tamarkin, Marja S. Huhta, Lonnie D. Myer, Jay Friedman, David G. I. Kingston
201678
13
Resistance to CTLA-4 checkpoint inhibition reversed through selective elimination of granulocytic myeloid cells
Oncotarget ·Paúl E. Clavijo, Ellen Moore, Jianhong Chen, Ruth J. Davis, Jay Friedman, Young Kim, Carter Van Waes, Zhong Chen, Clint Allen
201776
14
A Novel Nuclear Factor-κB Gene Signature Is Differentially Expressed in Head and Neck Squamous Cell Carcinomas in Association with TP53 Status
Clinical Cancer Research ·TL Lee, Xin Yang, Bin Yan, Jay Friedman, Praveen Duggal, Lorena Bagain, Gang Dong, Ning T. Yeh, Jie Wang, Jian Zhou, Abdel Elkahloun, Carter Van Waes, Zhong Chen
200769
15
Nuclear factor-κB p65 small interfering RNA or proteasome inhibitor bortezomib sensitizes head and neck squamous cell carcinomas to classic histone deacetylase inhibitors and novel histone deacetylase inhibitor PXD101
Molecular Cancer Therapeutics ·Jianming Duan, Jay Friedman, Liesl Nottingham, Zhong Chen, Gulshan Ara, Carter Van Waes
200765
16
Neoadjuvant PD-1 Immune Checkpoint Blockade Reverses Functional Immunodominance among Tumor Antigen–Specific T Cells
Clinical Cancer Research ·Jay Friedman, Ellen Moore, Paul Zolkind, Yvette Robbins, Paúl E. Clavijo, Lillian Sun, Sarah Greene, Megan V. Morisada, Wojciech K. Mydlarz, Nicole C. Schmitt, James W. Hodge, Hans Schreiber, Carter Van Waes, Ravindra Uppaluri, Clint Allen
201965
17
Genome-wide identification of novel expression signatures reveal distinct patterns and prevalence of binding motifs for p53, nuclear factor-κB and other signal transcription factors in head and neck squamous cell carcinoma
Genome biology ·Bin Yan, Xinping Yang, TL Lee, Jay Friedman, Jun Tang, Carter Van Waes, Zhong Chen
200750
18
Proteomic Signatures of Epidermal Growth Factor Receptor and Survival Signal Pathways Correspond to Gefitinib Sensitivity in Head and Neck Cancer
Clinical Cancer Research ·Francisco G. Pernas, Clint Allen, Mary Winters, Bin Yan, Jay Friedman, Bhavana Dabir, Kunal Saigal, Gerhard S. Mundinger, Xiaojiang Xu, John C. Morris, Katherine R. Calvo, Carter Van Waes, Zhong Chen
200949
19
Deficient TP53 Expression, Function, and Cisplatin Sensitivity Are Restored by Quinacrine in Head and Neck Cancer
Clinical Cancer Research ·Jay Friedman, Liesl Nottingham, Praveen Duggal, Francisco G. Pernas, Bin Yan, Xin Yang, Zhong Chen, Carter Van Waes
200749
20
WEE1 kinase inhibition reverses G2/M cell cycle checkpoint activation to sensitize cancer cells to immunotherapy
OncoImmunology ·Lillian Sun, Ellen Moore, Rose Berman, Paúl E. Clavijo, Anthony D. Saleh, Zhong Chen, Carter Van Waes, John Davies, Jay Friedman, Clint Allen
201848

About Jay Friedman

Jay Friedman is a scholar working on Oncology, Immunology, Molecular Biology, Cancer Research and Epidemiology, having authored 56 papers that have together received 2.7k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (9 papers), Immune cells in cancer (8 papers), NF-κB Signaling Pathways (7 papers), Immunotherapy and Immune Responses (6 papers), Cancer-related Molecular Pathways (5 papers), CAR-T cell therapy research (4 papers), interferon and immune responses (3 papers) and Immune Cell Function and Interaction (3 papers). The work is most often cited by research in Immunology (998 citations), Oncology (1.1k citations), Otorhinolaryngology (107 citations), Cancer Research (317 citations) and Molecular Biology (749 citations). Jay Friedman has collaborated with scholars based in United States, Germany and Malaysia. Frequent co-authors include Carter Van Waes, Clint Allen, Paúl E. Clavijo, Zhong Chen, Ellen Moore, Yvette Robbins, Jeffrey Schlom, Husam Ghanim, Paresh Dandona and Priya Mohanty. Their work appears in journals such as Clinical Cancer Research, Oral Oncology, Cancer Research, OncoImmunology and Journal for ImmunoTherapy of Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Fabrice JournéBreakdown of academic impact, for papers by Kwan‐Hwa ChiBreakdown of academic impact, for papers by Mélanie BruchardBreakdown of academic impact, for papers by Caio A. LeiteBreakdown of academic impact, for papers by Shih Sheng JiangBreakdown of academic impact, for papers by Eric Kenneth ParkinsonBreakdown of academic impact, for papers by Yanhong NiBreakdown of academic impact, for papers by Ko‐Jiunn LiuBreakdown of academic impact, for papers by Wan DuBreakdown of academic impact, for papers by Laura S. Angelo